Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
Below is a practical, risk-aware 48-hour plan designed to (1) protect patients immediately, (2) meet likely regulatory expectations even if formal reporting takes months, (3) reduce legal exposure by demonstrating diligence and good faith, and (4) stabilize the market with an ethical, transparent communications…Read the full answer
My north star: We disclose—fast, fully, and on our terms. The “wait for more data” option is a mirage. It exposes the company to criminal liability under FDA adverse-event reporting rules, potential DOJ investigation, securities fraud charges, and derivative litigation that could destroy the firm.Read the full answer